Suzan Imren
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
Papers in
- Hematology 24
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 10
-
- CRISPR and Genetic Engineering 8
- RNA Interference and Gene Delivery 6
- Co-authors
- Yves A. DeClerck (5 shared papers)R. Keith Humphries (19 shared papers)Connie J. Eaves (12 shared papers)Laurence Blavier (2 shared papers)Philippe Leboulch (5 shared papers)Mary E. Fabry (5 shared papers)Ronald L. Nagel (5 shared papers)Robert Pawliuk (3 shared papers)
- Journals
- Blood (11 papers)Experimental Hematology (4 papers)Journal of Biological Chemistry (2 papers)Leukemia (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Suzan Imren
38 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 92
- Hematology 407
- Cancer Research 373
- Genetics 246
- Immunology and Allergy 96
- Oncology 380
Countries citing papers authored by Suzan Imren
This map shows the geographic impact of Suzan Imren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzan Imren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzan Imren more than expected).
Fields of papers citing papers by Suzan Imren
This network shows the impact of papers produced by Suzan Imren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzan Imren. The network helps show where Suzan Imren may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzan Imren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 192 | |
| 2 | 2002 | 148 | |
| 3 | 2016 | 118 | |
| 4 | Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. | 1996 | 115 |
| 5 | 1994 | 108 | |
| 6 | 2004 | 99 | |
| 7 | 1997 | 99 | |
| 8 | 2004 | 94 | |
| 9 | 1999 | 84 | |
| 10 | 2007 | 65 | |
| 11 | 2000 | 54 | |
| 12 | 2011 | 39 | |
| 13 | 2011 | 34 | |
| 14 | 2004 | 32 | |
| 15 | 2016 | 30 | |
| 16 | 2018 | 23 | |
| 17 | 1997 | 21 | |
| 18 | 2010 | 21 | |
| 19 | Changes observed in the growth fraction, labeling index, duration of S phase, and total cell cycle times of HL-60 cells as they undergo differentiation in response to retinoic acid. | 1988 | 21 |
| 20 | 2014 | 20 |
About Suzan Imren
Suzan Imren is a scholar working on Hematology, Molecular Biology, Genetics, Genetics and Oncology, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (10 papers), Hemoglobinopathies and Related Disorders (9 papers), CRISPR and Genetic Engineering (8 papers), RNA Interference and Gene Delivery (6 papers), Virus-based gene therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and Protease and Inhibitor Mechanisms (4 papers). The work is most often cited by research in Hematology (407 citations), Cancer Research (373 citations), Genetics (246 citations), Immunology and Allergy (96 citations) and Oncology (380 citations). Suzan Imren has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Yves A. DeClerck, R. Keith Humphries, Connie J. Eaves, Laurence Blavier, Philippe Leboulch, Mary E. Fabry, Ronald L. Nagel, Robert Pawliuk, Karen A. Westerman and Donald B. Kohn. Their work appears in journals such as Blood, Experimental Hematology, Journal of Biological Chemistry, Leukemia and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.